HG Vora Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,750,000
Closed -$10.8M 17
2023
Q2
$10.8M Sell
2,750,000
-1,750,000
-39% -$5.55M 0.31% 14
2023
Q1
$15.2M Sell
4,500,000
-3,376,453
-43% -$13.8M 0.44% 16
2022
Q4
$28.2M Hold
7,876,453
1.13% 12
2022
Q3
$31.7M Hold
7,876,453
1.43% 14
2022
Q2
$35.1M Hold
7,876,453
1.39% 16
2022
Q1
$66.9M Hold
7,876,453
1.97% 17
2021
Q4
$69.5M Hold
7,876,453
2.49% 14
2021
Q3
$81.9M Hold
7,876,453
3.1% 12
2021
Q2
$82.7M Buy
7,876,453
+5,376,453
+215% +$53.1M 3.73% 10
2021
Q1
$25.7M Buy
2,500,000
+500,000
+25% +$6.96M 1.37% 18
2020
Q4
$22.2M Buy
+2,000,000
New +$20.4M 1.72% 18

Other funds holding SRTA

HG Vora Capital Management's SRTA Position: Q3 2023 in Review

HG Vora Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2023, closing a stake of 2,750,000 shares — an estimated $10.8M sold.

HG Vora Capital Management first reported a position in SRTA in Q4 2020 and held it in 11 quarters. The position peaked at $82.7M in Q2 2021. 105 funds tracked by Wall St. Rank hold SRTA as of Q3 2023.

  • HG Vora Capital Management reported no remaining Strata Critical Medical Inc position as of Q3 2023 after selling out during the quarter.
  • HG Vora Capital Management sold 2,750,000 Strata Critical Medical Inc shares in Q3 2023, an estimated $10.8M.
  • HG Vora Capital Management first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 11 quarters.
  • HG Vora Capital Management's Strata Critical Medical Inc position peaked at $82.7M in Q2 2021.
  • 105 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2023.

Based on HG Vora Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.